financetom
Business
financetom
/
Business
/
Since Embracing Bitcoin 4 Years Ago, Michael Saylor's MicroStrategy Has Outperformed Warren Buffett's Berkshire Hathaway Returns
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Since Embracing Bitcoin 4 Years Ago, Michael Saylor's MicroStrategy Has Outperformed Warren Buffett's Berkshire Hathaway Returns
Aug 12, 2024 1:53 AM

Software development firm MicroStrategy Inc. ( MSTR ) hasn't been the same since it embraced Bitcoin (CRYPTO: BTC) four years ago, with the firm's stock returning more to its investors than Warren Buffett's Berkshire Hathaway Inc. throughout this time.

What Happened: MicroStrategy ( MSTR ) adopted Bitcoin as its primary reserve asset on August 10, 2020, becoming the first publicly listed company to pursue this strategy. 

Since then, shares of the so-called Bitcoin development company have soared 839%. Interestingly, the stock has outperformed even Bitcoin's returns, with the cryptocurrency growing by 393%.

Meanwhile, Berkshire Hathaway's stock has just about doubled in value since Aug. 10, 2020, or a growth of 101%

It was pertinent to note that the firm's top executives have been some of the harshest critics of Bitcoin.

In an interview with CNBC in May 2018, Buffett described Bitcoin as "rat poison" and said he wouldn’t buy it even if it dropped to $25.

In May 2021, the late vice chairman Charlie Munger went to the extent of labeling the apex cryptocurrency "disgusting and contrary to the interests of civilization."

See Also: Bitcoin Skeptic Peter Schiff Says He Is ‘Open-Minded’ But Hasn’t Seen Any Convincing Argument To Embrace King Crypto: ‘I’m Also Intelligent And Honest’

Why It Matters: MicroStrategy’s Bitcoin corporate reserve strategy has been driven by its co-founder, Michael Saylor's unwavering support of the digital asset. 

He recently disclosed owning nearly $1 billion worth of BTCs in a personal capacity, separate from $13.2 billion worth of the currency held in MicroStrategy's ( MSTR ) reserves. 

At the current market value, the company's paper gains on Bitcoin were roughly 60%. The company also revealed plans to raise up to $2 billion through equity sales to acquire more Bitcoin.

Price Action: At the time of writing, Bitcoin was exchanging hands at $58,442.49, down 4.86% in the last 24 hours, according to data from Benzinga Pro. Shares of MicroStrategy ( MSTR ) ended 0.46% down at $135.37 at Friday’s market close.

Read Next: 

Nicolas Maduro’s Venezuela Blocks Access To Binance, Crypto Exchange Says Funds Are Safe

Image Via Shutterstock

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BRIEF-Keysight Technologies To Buy UK's Spirent Communications For $1.46 Bln
BRIEF-Keysight Technologies To Buy UK's Spirent Communications For $1.46 Bln
Mar 28, 2024
March 28 (Reuters) - Keysight Technologies Inc ( KEYS ): * RECOMMENDED CASH OFFER BY KEYSIGHT FOR SPIRENT COMMUNICATIONS PLC * KEYSIGHT TECHNOLOGIES INC ( KEYS ): OFFER IS FOR A CASH CONSIDERATION OF 199 PENCE PER SHARE * KEYSIGHT TECHNOLOGIES INC ( KEYS ): PROPOSED DEAL FOR APPROXIMATELY £1,158 MILLION * KEYSIGHT TECHNOLOGIES INC ( KEYS ): SPIRENT'S BOARD...
DBRS Confirms BCE, Bell Canada's Ratings
DBRS Confirms BCE, Bell Canada's Ratings
Mar 28, 2024
11:44 AM EDT, 03/28/2024 (MT Newswires) -- Morningstar DBRS on Thursday confirmed BCE's (BCE.TO) issuer rating of BBB and Bell Canada's issuer rating of BBB (high). Also, the rating agency confirmed BCE's short-term issuer rating, unsecured debentures credit rating, and all classes preferred shares credit rating as well as the credit ratings of Bell Canada and Bell-MTS Inc. All trends...
Labcorp Expands Diagnostic Reach With Strategic Deal For Select Assets Of BioReference Health
Labcorp Expands Diagnostic Reach With Strategic Deal For Select Assets Of BioReference Health
Mar 28, 2024
Laboratory Corporation Of America Holdings ( LH ) acquires certain operations of Opko Health, Inc ( OPK )‘s subsidiary BioReference Health. The assets Labcorp is acquiring generate about $100 million in annual revenue, with the transaction valued at $237.5 million. This strategic move is designed to expand Labcorp’s lab service network and enhance the availability of its high-quality clinical laboratory services. Under the agreement,...
FinWise Bancorp Names Jim Noone as President, Appoints Robert Wahlman as CFO
FinWise Bancorp Names Jim Noone as President, Appoints Robert Wahlman as CFO
Mar 28, 2024
11:41 AM EDT, 03/28/2024 (MT Newswires) -- FinWise Bancorp ( FINW ) said Thursday it named Jim Noone as president and appointed Robert Wahlman as chief financial officer. Wahlman succeeds Javvis Jacobson, who will stay with the bank as treasurer. Noone has been president of FinWise Bank. Wahlman was most recently CFO of Axiom Bank and Axiom Bancshares. Price: 10.08,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved